Relaxation, Depressive Symptoms, Quality of Life in People Living With HIV: a Pilot Study
Primary Purpose
HIV, Depressive Symptoms
Status
Completed
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Jacobson progressive muscular relaxation
Schultz's autogenic training
Sponsored by

About this trial
This is an interventional treatment trial for HIV focused on measuring HIV, depressive symptoms, quality of life, relaxation, viral load, CD4+ T cell count
Eligibility Criteria
Inclusion Criteria:
- Age > 18 years
- HIV diagnosis of at least two years
- Depressive symptoms between 5 and 14 in the PHQ-9 scale
- Untreated with antidepressants or psychotherapy
- Able to speak and understand French
Exclusion Criteria:
- Started antiretroviral treatment within the last 6 months
- Start or already receiving Interferon
Sites / Locations
- Research center CHUM
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Experimental
Experimental
No Intervention
Arm Label
Jacobson progressive muscular relaxation
Schultz's autogenic training
control
Arm Description
Jacobson progressive muscular relaxation
Schultz's autogenic training
The CG continued to receive their standard care. After data collection at the six-month follow-up, the CG participants were invited to attend one of two relaxation interventions.
Outcomes
Primary Outcome Measures
Change from baseline in depressive symptoms measured with Personal Health Questionnaire (PHQ-9) assessed at 3 months
Depressive symptoms at 3 months will be measured with Personal Health Questionnaire (PHQ-9)
Change from baseline in depressive symptoms measured with Personal Health Questionnaire (PHQ-9) assessed at 6 months
Depressive symptoms at 6 months will be measured with Personal Health Questionnaire (PHQ-9)
Change from baseline in depressive symptoms measured with Personal Health Questionnaire (PHQ-9)assessed at 1 month
Depressive symptoms at 1 month will be measured with Personal Health Questionnaire (PHQ-9)
Secondary Outcome Measures
Change from baseline in quality of life measured with (MOS-HIV) Medical Outcome Study-HIV assessed at 6 months
Quality of life at 6 months will be measured with MOS-HIV) Medical Outcome Study-HIV
Change from baseline in quality of life measured with MOS-HIV) Medical Outcome Study-HIV assessed at 3 months
Quality of life at 3 months will be measured with MOS-HIV) Medical Outcome Study-HIV
Full Information
NCT ID
NCT01901016
First Posted
July 10, 2013
Last Updated
May 4, 2021
Sponsor
Université de Montréal
Collaborators
RRISIQ, Laval University
1. Study Identification
Unique Protocol Identification Number
NCT01901016
Brief Title
Relaxation, Depressive Symptoms, Quality of Life in People Living With HIV: a Pilot Study
Official Title
Relaxation, Depressive Symptoms, Quality of Life, Immunological and Virological Status o in People Living With HIV: a Pilot Study
Study Type
Interventional
2. Study Status
Record Verification Date
May 2018
Overall Recruitment Status
Completed
Study Start Date
June 2013 (Actual)
Primary Completion Date
September 2015 (Actual)
Study Completion Date
December 2015 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Université de Montréal
Collaborators
RRISIQ, Laval University
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Progressive muscle relaxation (PMR) and autogenic training (AT) are effective relaxation techniques to reduce depressive symptoms. However, no studies on their effectiveness have been conducted among people living with HIV and depressive symptoms. The primary aim of this pilot study was to assess the feasibility and acceptability of PMR and AT interventions among people living with HIV who have depressive symptoms. A secondary aim was to assess the potential effectiveness of these interventions on depressive symptoms and quality of life.
Detailed Description
This study was a three-arm pilot randomized control trial with mixed methods. Participants were randomized to PMR, AT, or control group (CG), with four assessments (baseline, one-, three-, and six-month). The PMR and AT interventions consisted of six one-hour sessions of individual training over 12 weeks and home practice. Recruitment, attrition, and completion rates were calculated. Depressive symptoms and quality of life were assessed at all times. Participants' perceptions of the interventions were collected in semi-structured interviews.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
HIV, Depressive Symptoms
Keywords
HIV, depressive symptoms, quality of life, relaxation, viral load, CD4+ T cell count
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
42 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Jacobson progressive muscular relaxation
Arm Type
Experimental
Arm Description
Jacobson progressive muscular relaxation
Arm Title
Schultz's autogenic training
Arm Type
Experimental
Arm Description
Schultz's autogenic training
Arm Title
control
Arm Type
No Intervention
Arm Description
The CG continued to receive their standard care. After data collection at the six-month follow-up, the CG participants were invited to attend one of two relaxation interventions.
Intervention Type
Behavioral
Intervention Name(s)
Jacobson progressive muscular relaxation
Intervention Description
PMR involves learning to identify the tension in specific muscle groups by tightening and relaxing each muscle group. It includes three different exercises: 1) contraction-relaxation of 12 large muscle groups in the arms, legs, and trunk; 2) identification and relaxation of tensions without the need for movement or contractions; and 3) contraction-relaxation of 12 small muscle groups in the neck, eyes, and mouth
Intervention Type
Behavioral
Intervention Name(s)
Schultz's autogenic training
Intervention Description
AT is a relaxation technique that is based on body attitude, reduction of exterior stimulation, inner concentration, and mental repetition of verbal formulas [28]. These formulas are organized into six exercises: 1) heaviness; 2) warmth; 3) calm and regular heart function; 4) self-regulation of respiration; 5) warmth in the upper abdominal area; and 6) agreeable cooling of the forehead.
Primary Outcome Measure Information:
Title
Change from baseline in depressive symptoms measured with Personal Health Questionnaire (PHQ-9) assessed at 3 months
Description
Depressive symptoms at 3 months will be measured with Personal Health Questionnaire (PHQ-9)
Time Frame
baseline and 3 months
Title
Change from baseline in depressive symptoms measured with Personal Health Questionnaire (PHQ-9) assessed at 6 months
Description
Depressive symptoms at 6 months will be measured with Personal Health Questionnaire (PHQ-9)
Time Frame
baseline and 6 months
Title
Change from baseline in depressive symptoms measured with Personal Health Questionnaire (PHQ-9)assessed at 1 month
Description
Depressive symptoms at 1 month will be measured with Personal Health Questionnaire (PHQ-9)
Time Frame
baseline and 1 month
Secondary Outcome Measure Information:
Title
Change from baseline in quality of life measured with (MOS-HIV) Medical Outcome Study-HIV assessed at 6 months
Description
Quality of life at 6 months will be measured with MOS-HIV) Medical Outcome Study-HIV
Time Frame
baseline and 6 months
Title
Change from baseline in quality of life measured with MOS-HIV) Medical Outcome Study-HIV assessed at 3 months
Description
Quality of life at 3 months will be measured with MOS-HIV) Medical Outcome Study-HIV
Time Frame
baseline and 3 months
Other Pre-specified Outcome Measures:
Title
Change from baseline in viral load assessed at 6 months
Description
Change from baseline in viral load assessed at 6 months
Time Frame
baseline and 6 months
Title
Change from baseline in CD4+ T cells count at 6 months
Description
Change from baseline in CD4+ T cells count at 6 months
Time Frame
baseline and 6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age > 18 years
HIV diagnosis of at least two years
Depressive symptoms between 5 and 14 in the PHQ-9 scale
Untreated with antidepressants or psychotherapy
Able to speak and understand French
Exclusion Criteria:
Started antiretroviral treatment within the last 6 months
Start or already receiving Interferon
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Pilar Ramirez Garcia, PhD
Organizational Affiliation
Université de Montréal
Official's Role
Principal Investigator
Facility Information:
Facility Name
Research center CHUM
City
Montréal
State/Province
Quebec
ZIP/Postal Code
H2X 0A9
Country
Canada
12. IPD Sharing Statement
Citations:
PubMed Identifier
32621729
Citation
Ramirez-Garcia MP, Leclerc-Loiselle J, Gagnon MP, Cote J, Brouillette MJ, Thomas R. A mixed-method randomized feasibility trial evaluating progressive muscle relaxation or autogenic training on depressive symptoms and quality of life in people living with human immunodeficiency virus (HIV) who have depressive symptoms. J Complement Integr Med. 2020 Jul 3;18(1):165-174. doi: 10.1515/jcim-2019-0167.
Results Reference
derived
Learn more about this trial
Relaxation, Depressive Symptoms, Quality of Life in People Living With HIV: a Pilot Study
We'll reach out to this number within 24 hrs